Anthony Buisson

Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn’s Disease

Geert D’Haens, Séverine Vermeire, Guy Lambrecht et al. · Gastroenterology · 2018 · 299 citations · Full text

Veterinary Medicine, Clinical Sciences, Pharmacotherapy +12

Comparative Acceptability and Perceived Clinical Utility of Monitoring Tools

Anthony Buisson, Florent Gonzalez, Florian Poullenot et al. · Inflammatory Bowel Diseases · 2017 · 230 citations · Full text

Medicine, Internal Medicine, Comparative Effectiveness Research +15

Diffusion-Weighted Magnetic Resonance Imaging in Ileocolonic Crohn's Disease: Validation of Quantitative Index of Activity

Constance Hordonneau, Anthony Buisson, Julien Scanzi et al. · The American Journal of Gastroenterology · 2013 · 215 citations

Medicine, Radiology, Diagnostic Imaging +16

Diffusion‐weighted magnetic resonance imaging for detecting and assessing ileal inflammation in <scp>C</scp>rohn's disease

Anthony Buisson, Aurélie Joubert, P.F. Montoriol et al. · Alimentary Pharmacology & Therapeutics · 2013 · 199 citations · Full text

Medicine, Clinical Sciences, Radiology +17

One‐year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study

Aurélien Amiot, Mélanie Serrero, Laurent Peyrin‐Biroulet et al. · Alimentary Pharmacology & Therapeutics · 2017 · 177 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17